Chinese Drugmakers Target Expiring U.S. Patents
Imitating their Indian counterparts, the Chinese firms view acquiring...
Law360 (November 18, 2003, 12:00 AM EST) -- Chinese drugmakers are targeting expiring U.S. drug patents in a bid to accelerate their expansion plans, the South China Morning Post reported.
To view the full article, register now.